The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V97.12.3820PMID 11389022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IMGT, the international ImMunoGeneTics database

  2000cited by this paper
• Antibodies to tissue‐type plasminogen activator in plasma from patients with primary antiphospholipid syndrome

  2000cited by this paper
• Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

  2000cited by this paper
• Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis.

  2000cited by this paper
• Antiphospholipid antibodies and thrombosis.

  1999cited by this paper
• Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.

  1999cited by this paper
• The Putative Mechanism of Thrombosis in Antiphospholipid Syndrome: Impairment of the Protein C and the Fibrinolytic Systems by Monoclonal Anticardiolipin Antibodies

  1999cited by this paper
• Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients

  1999cited by this paper
• IMGT, the international ImMunoGeneTics database

  1999cited by this paper
• Control of early viral and bacterial distribution and disease by natural antibodies.

  1999cited by this paper
• Characterization of IgG monoclonal anti‐cardiolipin/anti‐β2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies

  1999cited by this paper
• Isolation, characterization and sequence analysis of five IgG monoclonal anti-beta 2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display.

  1999cited by this paper
• Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome.

  1999cited by this paper
• Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein.

  1999cited by this paper
• Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies.

  1998cited by this paper
• Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.

  1998cited by this paper
• A Comparison of Three Methods for Production of Human Hybridomas Secreting Autoantibodies

  1998cited by this paper
• The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.

  1997cited by this paper
• Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation.

  1997cited by this paper
• High Antibody Levels to Prothrombin Imply a Risk of Deep Venous Thrombosis and Pulmonary Embolism in Middle-aged Men

  1997cited by this paper
• A new method for the analysis and production of monoclonal antibody fragments originating from single human B cells.

  1997cited by this paper
• Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression.

  1997cited by this paper
• IMGT, the international ImMunoGeneTics database

  1997cited by this paper
• Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus

  1996cited by this paper
• A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice.

  1996cited by this paper
• The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution.

  1996cited by this paper
• Autoantibodies to Phospholipid-binding Plasma Proteins in Patients with Thrombosis and Phospholipid-reactive Antibodies

  1996cited by this paper
• "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding.

  1995cited by this paper
• Autoimmune Antiphospholipid Antibodies Are Directed against a Cryptic Epitope Expressed when β2-Glycoprotein I Is Bound to a Suitable Surface

  1995cited by this paper
• Design of cassette baculovirus vectors for the production of therapeutic antibodies in insect cells.

  1995cited by this paper
• Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.

  1995cited by this paper
• A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded.

  1995cited by this paper
• Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells

  1995cited by this paper
• Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.

  1994cited by this paper
• The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement.

  1994cited by this paper
• Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes.

  1994cited by this paper
• Anti‐annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody

  1994cited by this paper
• Antiphospholipid antibodies and thrombosis.

  1994cited by this paper
• Establishment of two distinct anti-cardiolipin antibody-producing cell lines from the same individual by Epstein-Barr virus transformation.

  1994cited by this paper
• beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome.

  1994cited by this paper
• Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

  1994cited by this paper
• Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

  1993cited by this paper
• Characterization of a human monoclonal autoantibody directed to cardiolipin/β2 glycoprotein I produced by chronic lymphocytic leukaemia B cells

  1993cited by this paper
• Human anti‐self antibodies with high specificity from phage display libraries.

  1993cited by this paper
• Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections.

  1993cited by this paper
• In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells.

  1992cited by this paper
• Generation of Human Monoclonal Autoantibody-Producing Cell Lines by Epstein-Barr Virus Transformation of Autoreactive B Lymphocytes and by Somatic Cell Hybridization Techniques: Application to the Analysis of the Autoimmune B Cell Repertoire.

  1992cited by this paper
• Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.

  1992cited by this paper
• Lupus Anticoagulant Activity Is Frequently Dependent on the Presence of β2-Glycoprotein I

  1992cited by this paper
• Clinical manifestations of the antiphospholipid syndrome

  1992cited by this paper
• Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).

  1992cited by this paper
• Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin

  1991cited by this paper
• Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning.

  1991cited by this paper
• Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

  1990cited by this paper
• Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

  1990cited by this paper
• Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

  1989cited by this paper
• Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin.

  1989cited by this paper
• Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus.

  1988cited by this paper
• Human lymphocyte hybridomas and monoclonal antibodies.

  1986cited by this paper
• Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases

  1985cited by this paper
• Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

  1983cited by this paper
• Production of autoantibodies by human-human hybridomas.

  1982cited by this paper

• The absence of standardization in antiphospholipid antibody testing may favor the use of 99th percentile cutoffs in antiphospholipid syndrome classification

  2025cites this paper
• Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome

  2024cites this paper
• Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.

  2023cites this paper
• B cells in primary antiphospholipid syndrome: Review and remaining challenges.

  2021cites this paper
• Lipid presentation by the protein C receptor links coagulation with autoimmunity

  2021influential citation
• Understanding and measuring human B‐cell tolerance and its breakdown in autoimmune disease

  2019cites this paper
• Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.

  2019cites this paper
• Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops

  2017cites this paper
• Identification of autoreactive B cells with labeled nucleosomes

  2017cites this paper
• Antiphospholipid Antibodies: Their Origin and Development

  2016cites this paper
• Evaluation of antiphospholipid antibody assays using latent class analysis to address the lack of a reference standard

  2016cites this paper
• Profils cliniques et biologiques associés à la persistance des anticorps antiphospholipides au-delà de douze semaines

  2015cites this paper
• A STUDY OF NATURAL OCCURRING ANTICOAGULANT AND ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH HISTORY OF THROMBOSIS IN TEHRAN

  2013cites this paper
• Receptors involved in cell activation by antiphospholipid antibodies.

  2013cites this paper
• haystack Pathogenic antiphospholipid antibody: an antigen-selected needle in a

  2013cites this paper
• antibodies are present in healthy individuals Memory B cells producing somatically mutated antiphospholipid

  2013cites this paper
• Insights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy.

  2012cites this paper
• ise au point spects immunologiques du syndrome des antiphospholipides mmunological aspects of the antiphospholipid syndrome

  2012cites this paper
• Lepidopteran cells, an alternative for the production of recombinant antibodies?

  2012cites this paper
• [Immunological aspects of the antiphospholipid syndrome].

  2012cites this paper
• Standardization of antiphospholipid antibody assays. Where do we stand?

  2012cites this paper
• Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid‐induced pregnancy loss

  2011cites this paper
• Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin.

  2011cites this paper
• Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies

  2010cites this paper
• Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies

  2010cites this paper
• Tm4SF2 und lysosomales TMEM9B: Neue Zielantigene von B-Zell-Rezeptoren in

  2010cites this paper
• Engineering and characterization of a baculovirus-expressed mouse/human chimeric antibody against transferrin receptor.

  2009cites this paper
• Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function

  2008cites this paper
• The antiphospholipid syndrome.

  2008cites this paper
• [Pathogenesis of the antiphospholipid syndrome].

  2007cites this paper
• A recombinant human monoclonal anti-R7V antibody as a potential therapy for HIV infected patients in failure of HAART

  2007cites this paper
• [Physiopathology of the antiphospholipid syndrome].

  2007cites this paper
• Physiopathologie du syndrome des antiphospholipides

  2007cites this paper
• Physiopathology of the antiphospholipid syndrome

  2007cites this paper
• Chapter 19 – The Antiphospholipid Syndrome: Clinical Presentation, Diagnosis, and Patient Management

  2007cites this paper
• Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.

  2006cites this paper
• Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with antithrombin antibody from a patient with antiphospholipid syndrome

  2005cites this paper
• Anti‐lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus

  2005cites this paper
• Generation and Characterization of Three Monoclonal IgM Antiphospholipid Antibodies Recognizing Different Phospholipid Antigens

  2005cites this paper
• Multivalent compounds for antigen-specific B cell tolerance and treatment of autoimmune diseases.

  2005cites this paper
• Lessons from Sequence Analysis of Monoclonal Antiphospholipid Antibodies

  2005cites this paper
• Antiphospholipid antibodies: recent progresses on their origin and pathogenicity.

  2004cites this paper
• The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases.

  2004cites this paper
• Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome

  2004cites this paper
• Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice.

  2004cites this paper
• Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack.

  2004cites this paper
• Anticorps antiphospholipides : progrès récents concernant leur origine et leur pathogénicité

  2004cites this paper
• Antiphospholipid syndrome: multiple mechanisms

  2004cites this paper
• Annexinopathy in the Antiphospholipid Syndrome

  2003cites this paper
• Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.

  2003cites this paper
• L'effet des statines sur l'activation des cellules endothéliales par les anticorps antiphospholipides

  2003cites this paper
• A Single Intravenous Infusion of Apoptotic Cells, An Alternative Cell-Based Therapy Approach Facilitating Hematopoietic Cell Engraftment, Did Not Induce Autoimmunity

  2003cites this paper
• [Antiphospholipid syndrome updating].

  2003cites this paper
• Autoimmune disease as a cause of reproductive failure.

  2003cites this paper
• Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals.

  2003cites this paper
• Actualización del síndrome antifosfolipídico

  2003cites this paper
• Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies.

  2002cites this paper
• β2-glycoprotein-I and Anti-β2-glycoprotein-I Antibodies1

  2002cites this paper
• Molecular Pathogenesis of the Antiphospholipid Syndrome

  2002cites this paper
• Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis New Tricks for Old Dogs: Nonthrombotic Effects of Thrombin in Vessel Wall Biology Regulation of Vascular Bed–Specific Prothrombotic Potential Molecular Pathogenesis of the Antiphospholipid Syndrome Insights Into Mechanisms of T

  2001cites this paper
• Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association

  year unknowncites this paper